M Šustrová

436 total citations
15 papers, 349 citations indexed

About

M Šustrová is a scholar working on Clinical Biochemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M Šustrová has authored 15 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Clinical Biochemistry, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M Šustrová's work include Advanced Glycation End Products research (4 papers), Down syndrome and intellectual disability research (3 papers) and Frailty in Older Adults (2 papers). M Šustrová is often cited by papers focused on Advanced Glycation End Products research (4 papers), Down syndrome and intellectual disability research (3 papers) and Frailty in Older Adults (2 papers). M Šustrová collaborates with scholars based in Slovakia, United States and Austria. M Šustrová's co-authors include Jana Muchová, Iveta Garaiová, Zdeňka Ďuračková, Peter Korytár, Ingrid Žitňanová, A Nagyová, Katarı́na Rašlová, P. Kvasnička, A Liptáková and Okezie I. Aruoma and has published in prestigious journals such as Free Radical Biology and Medicine, Clinica Chimica Acta and Clinical & Experimental Immunology.

In The Last Decade

M Šustrová

15 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Šustrová Slovakia	10	115	78	47	46	40	15	349
Alejandra M. Wiedeman Canada	7	60 0.5×	76 1.0×	41 0.9×	94 2.0×	68 1.7×	15	360
Svetlana V. Konstantinova Russia	10	139 1.2×	140 1.8×	58 1.2×	50 1.1×	131 3.3×	19	516
Erkan Söğüt Türkiye	13	68 0.6×	52 0.7×	15 0.3×	23 0.5×	30 0.8×	36	397
Catherine A. Chenard United States	13	113 1.0×	165 2.1×	165 3.5×	65 1.4×	165 4.1×	24	643
Nicole E. G. Wijckmans Netherlands	10	137 1.2×	49 0.6×	39 0.8×	57 1.2×	127 3.2×	12	342
J. Folkard United Kingdom	6	84 0.7×	40 0.5×	34 0.7×	34 0.7×	69 1.7×	8	304
Sermet Yıldırmış Türkiye	9	35 0.3×	49 0.6×	27 0.6×	36 0.8×	42 1.1×	19	375
Farideh Shiraseb Iran	11	191 1.7×	67 0.9×	14 0.3×	71 1.5×	146 3.6×	72	476
Franco Mastroianni Italy	10	73 0.6×	46 0.6×	9 0.2×	69 1.5×	143 3.6×	25	389
Anne‐Sophie Rousseau France	13	94 0.8×	58 0.7×	9 0.2×	81 1.8×	149 3.7×	24	481

Countries citing papers authored by M Šustrová

Since Specialization

Citations

This map shows the geographic impact of M Šustrová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Šustrová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Šustrová more than expected).

Fields of papers citing papers by M Šustrová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Šustrová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Šustrová. The network helps show where M Šustrová may publish in the future.

Co-authorship network of co-authors of M Šustrová

This figure shows the co-authorship network connecting the top 25 collaborators of M Šustrová. A scholar is included among the top collaborators of M Šustrová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Šustrová. M Šustrová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Schipp, Dorothea, Jana Tulinská, M Šustrová, et al.. (2018). Consumption of a dark roast coffee blend reduces DNA damage in humans: results from a 4-week randomised controlled study. European Journal of Nutrition. 58(8). 3199–3206. 7 indexed citations

Smolková, Božena, Jana Tulinská, Ľubica Palkovičová, et al.. (2017). Impact of interleukin 13 (IL13) genetic polymorphism Arg130Gln on total serum immunoglobulin (IgE) levels and interferon (IFN)-γ gene expression. Clinical & Experimental Immunology. 188(1). 45–52. 11 indexed citations

Krajcovicová-Kudlácková, M, et al.. (2009). Plasma concentrations of selected antioxidants in autistic children and adolescents.. PubMed. 110(4). 247–50. 30 indexed citations

Muchová, Jana, Iveta Garaiová, M Šustrová, et al.. (2007). The redox state of glutathione in erythrocytes of individuals with Down syndrome.. PubMed. 108(2). 70–4. 9 indexed citations

Žitňanová, Ingrid, et al.. (2006). Markers of oxidative stress in children with Down syndrome. Clinical Chemistry and Laboratory Medicine (CCLM). 44(3). 306–10. 26 indexed citations

Žitňanová, Ingrid, Peter Korytár, Okezie I. Aruoma, et al.. (2004). Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?. Clinica Chimica Acta. 341(1-2). 139–146. 82 indexed citations

Muchová, Jana, et al.. (2001). Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of down syndrome patients. Free Radical Biology and Medicine. 31(4). 499–508. 74 indexed citations

Šustrová, M, et al.. (2001). Effects of a single transdermal nicotine dose on cognitive performance in adults with Down syndrome. PubMed. 237–245. 8 indexed citations

Nagyová, A, M Šustrová, & Katarı́na Rašlová. (2000). Serum Lipid Resistance to Oxidation and Uric Acid Levels in Subjects with Down's s Syndrome. Physiological Research. 227–231. 13 indexed citations

10.

Nagyová, A, M Šustrová, & Katarı́na Rašlová. (2000). Serum lipid resistance to oxidation and uric acid levels in subjects with Down's syndrome.. PubMed. 49(2). 227–31. 23 indexed citations

11.

Ďuračková, Zdeňka, Iveta Garaiová, Jana Muchová, A Liptáková, & M Šustrová. (1999). Metabolism of glutathione at the persons with down syndrom. Free Radical Biology and Medicine. 27. S120–S120. 3 indexed citations

12.

Pueschel, Siegfried M. & M Šustrová. (1997). Adolescents with Down syndrome : toward a more fulfilling life. 14 indexed citations

13.

Šustrová, M, et al.. (1997). [Down's syndrome--effect of increased gene expression in chromosome 21 on the function of the immune and nervous system].. PubMed. 98(4). 221–8. 7 indexed citations

14.

Kadrabová, J, A Madarić, M Šustrová, & E Ginter. (1996). Changed serum trace element profile in Down's syndrome. Biological Trace Element Research. 54(3). 201–206. 22 indexed citations

15.

Šustrová, M, et al.. (1994). Thyroid function and plasma immunoglobulins in subjects with Down’s syndrome (DS) during ontogenesis and zinc therapy. Journal of Endocrinological Investigation. 17(6). 385–390. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact